Hemal Mehta

University of Sydney — Australia

Medicine · Health Sciences

21h-index2.2kcitations95works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Diseases and Treatments(75), Retinal Imaging and Analysis(57), Retinal and Optic Conditions(49), Glaucoma and retinal disorders(13), Ocular Diseases and Behçet’s Syndrome(11)

Publications92 total

Twelve‐Month Outcomes of Brolucizumab in Routine Clinical Practice: Fight Retinal Blindness! Registry
Clinical and Experimental Ophthalmology·2025
Lost to Follow-Up in Neovascular Age-Related Macular Degeneration: A Systematic Review of Global Trends, Risk Factors, and Clinical Consequences
Ophthalmologica·2025
Minimum set of outcome measures for non-advanced age-related macular degeneration: a Delphi consensus statement by the TRACER (intermediate age-related macular degeneration) study group
British Journal of Ophthalmology·2025Open Access
A prospective, open-label, single-arm, investigator-initiated clinical trial to assess the efficacy, safety and durability of faricimab in patients with inadequate response to current treatment for neovascular age-related macular degeneration: protocol design and rationale for the FURGGHORN Study
BMJ Open Ophthalmology·2025Open Access
Outliers of Treatment Frequency in Retinal Vein Occlusion: 24‐Month Comparative Analysis of Fight Retinal Blindness! Practitioners
Clinical and Experimental Ophthalmology·2024· 2 citedOpen Access
Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion
Ophthalmology Retina·2024· 2 cited
One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity
Ophthalmology Retina·2024· 3 citedOpen Access
Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry
Scientific Reports·2024· 3 citedOpen Access
From randomised controlled trials to real-world data: Clinical evidence to guide management of diabetic macular oedema
Progress in Retinal and Eye Research·2023· 15 citedOpen Access
12-month outcomes of treatment-naïve retinal vein occlusion initially treated with either dexamethasone implants or vascular endothelial growth factor inhibitors: Data from the Fight Retinal Blindness! registry
2023Open Access
Novel Drug Delivery Methods and Approaches for the Treatment of Retinal Diseases
Asia-Pacific Journal of Ophthalmology·2023· 13 citedOpen Access
Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO)
Eye·2023· 5 citedOpen Access
Diabetic Macular Oedema Guidelines: An Australian Perspective
Journal of Ophthalmology·2023· 8 citedOpen Access
Reply
Ophthalmology Retina·2022· 1 cited
Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF
Ophthalmology Retina·2022· 11 citedOpen Access
Outcomes of Over 40,000 Eyes Treated for Diabetic Macula Edema in Routine Clinical Practice: A Systematic Review and Meta-analysis
Advances in Therapy·2022· 21 citedOpen Access
Risk Factors Associated with Post-Acute Sequelae of SARS-CoV-2 in an EHR Cohort: A National COVID Cohort Collaborative (N3C) Analysis as part of the NIH RECOVER program
2022· 32 citedOpen Access
Polypoidal Choroidal Vasculopathy Based on Non-ICGA Criteria in White Patients With Neovascular Age-Related Macular Degeneration
American Journal of Ophthalmology·2022· 5 cited
Author Correction: Neuroimaging and cognitive correlates of retinal Optical Coherence Tomography (OCT) measures at late middle age in a twin sample
Scientific Reports·2022· 2 citedOpen Access
Three-year treatment outcomes of Aflibercept versus Ranibizumab for diabetic macular edema:: Data from the Fight Retinal Blindness! Registry
Zurich Open Repository and Archive (University of Zurich)·2022· 9 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Mark C. Gillies(30), Vuong Nguyen(22), Samantha Fraser‐Bell(18), Daniel Barthelmes(16), Lyndell L. Lim(9), Ian L. McAllister(9), Pierre‐Henry Gabrielle(8), Jennifer Arnold(8), Adrian Hunt(7), Winfried M. K. Amoaku(6), Louise Downey(6), Javier Zarranz‐Ventura(6), Adnan Tufail(5), Dawn A. Sim(5), S. Bhandari(5), Anna Campain(4), Pearse A. Keane(4), Catherine Egan(4), Sajjad Mahmood(4), Francesco Viola(4)